Axiom Investors LLC Agios Pharmaceuticals, Inc. Transaction History

Axiom Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$32.4 - $49.58 $521,056 - $797,345	-16,082 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$46.17 - $68.1 $81,490 - $120,196	-1,765 Reduced 9.89%	16,082 $802,000
Q1 2019 May 13, 2019	BUY	$45.92 - $67.67 $301,924 - $444,930	6,575 Added 58.33%	17,847 $1.2 Million
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $539,936 - $967,033	-12,636 Reduced 52.85%	11,272 $520,000
Q3 2018 Nov 13, 2018	SELL	$71.67 - $91.95 $129,006 - $165,510	-1,800 Reduced 7.0%	23,908 $1.84 Million
Q2 2018 Aug 13, 2018	BUY	$73.22 - $99.55 $1.88 Million - $2.56 Million	25,708 New	25,708 $2.17 Million

226

56.3M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.5B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.